je.st
news
Navidea Biopharmaceuticals Downgraded by Zacks to "Sell"
2015-10-11 15:25:58| Biotech - Topix.net
According to Zacks, "Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek , AZD4694 and RIGScan .
Tags: sell
downgraded
zacks
biopharmaceuticals
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||